10x Genomics, Inc. Class A Common Stock TXG
i
Market dataready · fetched 2026-11-07T06:58:09.512Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-06T23:34:47.015699281Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-07T06:58:08.974449+00:00
10x Genomics, Inc. Class A Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 71.34 | 85.6% | 18.3% | 52.09 | 115.5% | 17.7% |
| 25Δ | 69.39 | 85.8% | 15.6% | 54.05 | 116.7% | 15.4% |
| 30Δ | 67.48 | 81.0% | 12.9% | 55.89 | 117.3% | 13.5% |
| 35Δ | 65.56 | 76.3% | 10.3% | 57.63 | 117.4% | 11.9% |
| 40Δ | 64.23 | 73.4% | 8.6% | 59.37 | 117.4% | 10.3% |
| 45Δ | 63.13 | 71.2% | 7.4% | 61.29 | 121.9% | 9.1% |
| 50Δ | 62.03 | 69.0% | 6.2% | 63.31 | 128.8% | 8.2% |
| 55Δ | 60.93 | 66.9% | 5.0% | 65.51 | 136.5% | 7.4% |
| 60Δ | 68.54 | 147.6% | 6.6% | |||
| 65Δ | 71.92 | 157.0% | 5.8% | |||
| 70Δ | 75.96 | 165.3% | 4.9% | |||
| 75Δ | ||||||
| 80Δ | 92.29 | 203.8% | 3.4% | |||
20Δ
- Pseudo strike
- 71.34
- IV
- 85.6%
- B/E move
- 18.3%
- Pseudo strike
- 52.09
- IV
- 115.5%
- B/E move
- 17.7%
25Δ
- Pseudo strike
- 69.39
- IV
- 85.8%
- B/E move
- 15.6%
- Pseudo strike
- 54.05
- IV
- 116.7%
- B/E move
- 15.4%
30Δ
- Pseudo strike
- 67.48
- IV
- 81.0%
- B/E move
- 12.9%
- Pseudo strike
- 55.89
- IV
- 117.3%
- B/E move
- 13.5%
35Δ
- Pseudo strike
- 65.56
- IV
- 76.3%
- B/E move
- 10.3%
- Pseudo strike
- 57.63
- IV
- 117.4%
- B/E move
- 11.9%
40Δ
- Pseudo strike
- 64.23
- IV
- 73.4%
- B/E move
- 8.6%
- Pseudo strike
- 59.37
- IV
- 117.4%
- B/E move
- 10.3%
45Δ
- Pseudo strike
- 63.13
- IV
- 71.2%
- B/E move
- 7.4%
- Pseudo strike
- 61.29
- IV
- 121.9%
- B/E move
- 9.1%
50Δ
- Pseudo strike
- 62.03
- IV
- 69.0%
- B/E move
- 6.2%
- Pseudo strike
- 63.31
- IV
- 128.8%
- B/E move
- 8.2%
55Δ
- Pseudo strike
- 60.93
- IV
- 66.9%
- B/E move
- 5.0%
- Pseudo strike
- 65.51
- IV
- 136.5%
- B/E move
- 7.4%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 68.54
- IV
- 147.6%
- B/E move
- 6.6%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 71.92
- IV
- 157.0%
- B/E move
- 5.8%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 75.96
- IV
- 165.3%
- B/E move
- 4.9%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 92.29
- IV
- 203.8%
- B/E move
- 3.4%
Options history
Table
| Date | IV (%) |
|---|---|
| 82.62% | |
| 83.26% | |
| 81.48% | |
| 78.88% | |
| 84.05% | |
| 90.68% | |
| 80.33% | |
| 83.24% | |
| 82.45% | |
| 82.61% | |
| 80.32% | |
| 83.25% | |
| 79.72% | |
| 83.23% | |
| 81.79% | |
| 79.95% | |
| 79.88% | |
| 83.74% | |
| 82.21% | |
| 81.43% | |
| 78.19% | |
| 85.30% | |
| 85.32% | |
| 85.44% | |
| 81.53% | |
| 82.84% | |
| 81.66% | |
| 82.86% | |
| 87.07% | |
| 88.63% | |
| 88.90% | |
| 89.28% | |
| 88.13% | |
| 86.83% | |
| 85.83% | |
| 95.35% | |
| 92.18% | |
| 93.38% | |
| 86.86% | |
| 95.24% | |
| 96.45% | |
| 97.18% | |
| 103.15% | |
| 89.60% | |
| 89.16% | |
| 90.13% | |
| 88.25% | |
| 90.20% | |
| 89.28% | |
| 91.73% | |
| 91.05% | |
| 91.24% | |
| 92.80% | |
| 96.09% |
Medical Devices
UFPT
UFP Technologies, Inc. designs and converts foams, films and plastic materials for the medical, automotive, consumer, electronic, industrial, aerospace and defense markets in the…
More →VMD
Description unavailable
More →VREX
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company is headquartered in Salt Lake City, Utah.
More →ZBH
Zimmer Biomet is a publicly traded medical device company. The company is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
More →ABT
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by…
More →AHCO
AdaptHealth Corp. The company is headquartered in Plymouth Meeting, Pennsylvania.
More →